Table 1.
Characteristics of the 14 patients at ICU admission
| Population study (N = 14) | |
|---|---|
| Median age, year (range) | 74 (53–84) |
| Age ≥65 year, n (%) | 10 (71) |
| Male sex, n (%) | 11 (79) |
| Median SAPS‐2 (range) | 37 (24–53) |
| Median SOFA (range) | 4 (0–8) |
| Median time to onset of symptoms, days (range) | 9 (5–24) |
| Median PaO2/FiO2, mmHg (range) | 117 (50–400) |
| Coexisting conditions, n (%) | |
| BMI above 30 kg/m2 | 2 (14) |
| Hypertension | 10 (71) |
| Diabetes | 4 (29) |
| Chronic obstructive pulmonary disease | 1 (7) |
| Congestive heart failure | 0 (0) |
| Chronic renal failure | 3 (21) |
| Solid tumors | 5 (36) |
| Hematologic cancer | 4 (29) |
| Chest CT‐scan parenchymal involvement | |
| <25% | 4 (29) |
| 25%–50% | 3 (21) |
| 50%–75% | 5 (36) |
| >75% | 2 (14) |
| Pulmonary embolism | 1 (7) |
| Respiratory support, n (%) | |
| Low‐flow oxygen nasal cannula | 2 (14) |
| High‐flow oxygen nasal cannula | 6 (43) |
| Noninvasive ventilation | 3 (21) |
| Invasive ventilation | 6 (43) |
| Associated treatments, n (%) | |
| Glucocorticoids | 13 (93) |
| Tocilizumab | 12 (86) |
| Heparin | 14 (100%) |
Abbreviations: BMI, body mass index; ICU, intensive care unit; SAPS‐2, simplified acute physiology score; SOFA, sequential organ failure assessment.